Analyst Price Targets — NVAX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 24, 2025 11:45 am | — | Cantor Fitzgerald | $18.00 | $8.55 | TheFly | Novavax initiated with an Overweight at Cantor Fitzgerald |
| October 23, 2025 12:20 pm | Sean Lee | H.C. Wainwright | $11.00 | $8.46 | TheFly | Novavax price target raised to $11 from $10 at H.C. Wainwright |
| November 18, 2024 12:39 pm | Mayank Mamtani | B.Riley Financial | $22.00 | $7.58 | StreetInsider | Novavax (NVAX) PT Lowered to $22 at B.Riley |
| October 16, 2024 1:29 pm | Roger Song | Jefferies | $25.00 | $10.15 | StreetInsider | Novavax (NVAX) PT Lowered to $25 at Jefferies |
| October 16, 2024 11:43 am | Alec Stranahan | Bank of America Securities | $14.00 | $10.45 | StreetInsider | Novavax (NVAX) PT Lowered to $14 at BofA Securities 'to reflect delays in phase 3 CIC/standalone flu trial' |
| July 19, 2024 11:37 am | Roger Song | Jefferies | $31.00 | $14.36 | TheFly | Novavax price target lowered to $31 from $38 at Jefferies |
| May 10, 2024 10:56 am | Vernon Bernardino | H.C. Wainwright | $19.00 | $9.94 | TheFly | H.C. Wainwright reiterates Buy rating on Novavax after 'landmark' Sanofi deal |
| February 14, 2022 12:00 am | Charles Duncan | Cantor Fitzgerald | $174.00 | $80.11 | Pulse 2.0 | Novavax (NVAX) Stock: $174 Price Target From Cantor Fitzgerald |
Latest News for NVAX
In the most recent trading session, Novavax (NVAX) closed at $10.11, indicating a +1.1% shift from the previous trading day.
Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Cancer vaccine momentum is doing the work for Moderna (NASDAQ:MRNA | MRNA Price Prediction) once again on Thursday, extending one of the sharpest one-month runs in large-cap biotech this year without a fresh disclosure attached to it.
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the most recent trading session, Novavax (NVAX) closed at $9.42, indicating a +1.29% shift from the previous trading day.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for NVAX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.